Skip to main content

Top Left Menu

  • Careers
  • Media
  • Investors
  • Library

What are you looking for?

Home

You are here

Galderma Global

Choose another location

  • Argentina
  • Australia
  • Austria
  • Belgium
  • Brazil
  • Canada
  • Chile
  • Colombia
  • Czech Republic
  • Denmark
  • Finland
  • France
  • Germany
  • Hong Kong/Macau SAR, China
  • India
  • Italy
  • Japan
  • Kingdom of Saudi Arabia
  • Korea
  • Mainland China
  • Mexico
  • Middle East
  • Netherlands
  • Nordic
  • Norway
  • Poland
  • Portugal
  • Russia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Taiwan, China
  • Thailand
  • United Kingdom
  • United States
  • Venezuela

Top menu

  • Contact us
  • Search

Main navigation

  • About us
    • At a glance
    • Our purpose
    • Our strategy
    • Our sub-categories
    • Global presence
    • Executive Committee
    • Governance
    • Annual Report 2025
  • Skin Stories
    • Galderma skin stories
    • Skin Science
    • Beauty x Medicine
    • Galderma Insights
    • Podcasts
  • Innovation
    • Bringing innovation to life
    • Partnerships
    • Manufacturing
    • Early Access
  • Our brands
  • Sustainability
    • For our employees
    • For patients and consumers
    • For healthcare professionals and customers
    • Governance oversight
    • Funding request for education and support activities
    • Our ESG Index
  • Media
  • Careers
  • Investors
You searched for: «【✈️ Telegram ID: KPU77】 대성피 성인 피시방 안전 보장 100% 알거래 중개소 리스트 - 용인»
Results 86 - 90 of 155
Page 18 of 31
  1. Media
  2. Newsroom

Galderma Announces FDA Approval of Restylane® Lyft For Midface Injection via Cannula

First and Only Hyaluronic Acid Dermal Filler for Cheeks with Cannula1 Now Offers Aesthetic Professionals New Delivery Method of Injectable Treatment 

 

  1. Media
  2. Newsroom

Galderma to acquire award-winning ALASTIN Skincare® enhancing its integrated dermatology platform to continue delivering the best experience to patients

  • ALASTIN Skincare® was the fastest growing brand in the U.S. professional skincare market in 20201
  • ALASTIN’s patented, differentiated technology and products are highly synergistic with Galderma’s premium portfolio
  • Galderma will support further product innovation and geographical expansion of ALASTIN’s portfolio

 

  1. Media
  2. Newsroom

Galderma launches new Alastin Regenerating Skin Nectar with TriHex+™, powered by its next-generation TriHex Technology® regenerative platform

  • Regenerating Skin Nectar has long played a central role in the peri-procedural skin journey as part of Alastin’s dedicated procedure support portfolio, enhancing the body’s natural processes for removing damaged collagen and elastin while creating an optimal environment for new, healthy collagen and elastin production — visibly improving how the skin prepares for, responds to, and
  1. Media
  2. Newsroom

Galderma and Children’s Skin Disease Foundation Celebrate Decade-Long Partnership

Committed to advancing dermatology for every skin story, Galderma continues steadfast support of Camp Wonder, an annual sleepaway camp for children with life-threatening skin diseases

  1. Media
  2. Newsroom

World-Renowned Celebrity and Fashion Manicurist Deborah Lippmann Joins Forces with Galderma on “Face Your Hands” Campaign to Help Women Achieve Younger-Looking Hands with Restylane® Lyft

Fort Worth, TX – (September 25, 2018) – Galderma Laboratories, L.P., a global leader focused on meeting the world’s increasing skin health needs, announced today that Restylane® Lyft will partner with celebrity manicurist Deborah Lippmann on the “Face Your Hands” campaign to educate women on the steps they can take to achieve more beautiful, younger-looking hands.

Results 86 - 90 of 155
Page 18 of 31

Pagination

  • Previous page Previous Page
  • Next page Next Page
  1. Home
  2. Search results

STAY CONNECTED

Follow us on Social Media for current news and patients stories

Instagram LinkedIn Icon Twitter Icon
© Galderma 2026

Footer menu 2

  • Terms of use
  • Cookie Policy
  • Privacy
  • Sitemap

Confirm navigation

You are about to leave the Galderma global site. Are you sure you want to leave this page?

Yes, thanks Go back